CGM at the Met Gala: who benefits when diabetes tech becomes fashionable?

Libre Life Brief

• A CGM spotted at the Met Gala sparked debate about fashion and wearable health tech
• CGMs were developed to help people manage diabetes, not as lifestyle accessories
• Consumer wellness glucose tracking is changing public perception
• Medtech companies benefit when glucose monitoring expands beyond diabetes
• For most CGM users, practical issues matter far more than fashion

Introduction

When the popular media highlighted a continuous glucose monitor being worn at the Met Gala, it created the kind of headline designed to trigger instant conversation.

Has glucose monitoring become fashionable?

Is a CGM now the latest wearable health tech statement piece?

Has diabetes medtech entered the celebrity fashion world?

It is a provocative idea.

But it also risks missing the bigger story.

Because for millions of people, a CGM is not a futuristic accessory or wellness gadget.

It is essential medtech used every day to help manage diabetes.

And while fashion headlines make for easy clicks, they also tell us something revealing about where glucose monitoring is heading.

Not necessarily for people living with diabetes.

But certainly for the companies selling it.

From hidden diabetes tech to visible wearable health tech

Not that long ago, diabetes technology was designed to disappear.

Insulin pumps were clipped discreetly under clothing. Glucose meters stayed hidden in bags or pockets. Tubing was concealed wherever possible.

Visibility was rarely the goal.

Partly because older diabetes tech was bulkier and harder to integrate into daily life.

But also because many people simply preferred privacy.

Modern CGMs changed that.

FreeStyle Libre made upper-arm glucose sensors far more visible in everyday life. Dexcom sensors became increasingly familiar in gyms, offices, airports and social media posts.

Smaller, cleaner design made that possible.

But users themselves drove the cultural shift.

Parents shared stories.

Athletes posted glucose graphs.

Users discussed overnight compression lows, false alarms, sensor failures, adhesion frustrations and ways to stop sensors being knocked off.

Visibility became ordinary.

That matters.

But it is not the same thing as fashion endorsement.

The consumer wellness boom changed the meaning of a CGM

For years, a visible glucose sensor strongly suggested diabetes.

That is no longer necessarily true.

The rapid rise of consumer glucose tracking has transformed how people interpret a CGM.

Dexcom’s Stelo opened over-the-counter glucose monitoring in the United States.

Abbott’s Lingo targets consumers interested in metabolic insights rather than diabetes management.

Platforms such as Levels, Nutrisense and Ultrahuman have helped position glucose data as performance information.

That changes public perception dramatically.

A glucose sensor may still mean diabetes.

But it may equally signal wellness tracking, nutrition experimentation or fitness optimisation.

That is a major commercial opportunity.

And one medtech manufacturers clearly recognise.

Because expanding CGM adoption beyond diabetes creates a much bigger market.

More users.

More recurring sensor sales.

More subscription ecosystems.

More data platforms.

More investor enthusiasm.

Viewed in that context, a CGM appearing in celebrity culture feels less like a random moment and more like part of a broader repositioning.

Fashion has always embraced technology

Fashion routinely absorbs visible technology.

Eyewear evolved from necessity into style.

Smartwatches became premium accessories.

Smart rings became wellness status symbols.

A CGM fits surprisingly neatly into that world.

Minimal.

Geometric.

Body-worn.

Futuristic.

Visually clean.

Fashion naturally notices objects like that.

So a glucose sensor appearing in celebrity coverage is not particularly surprising.

But public interpretation does not change original purpose.

A FreeStyle Libre sensor remains diabetes medtech whether it appears in a hospital, gym or fashion column.

Still, narratives shape perception.

And perception shapes markets.

Is stigma really the issue?

One predictable response to visible diabetes tech in public is celebration around stigma reduction.

For some users, that absolutely matters.

Unwanted questions.

Assumptions.

Feeling visibly different.

Those experiences are real.

But stigma is also sometimes overstated.

And that can conveniently align with corporate narratives.

Because for many CGM users, stigma is not the most pressing concern.

The daily frustrations are much more practical.

Sensors peeling off too early.

Compression lows overnight.

False alerts.

Sensor inaccuracies.

Replacement delays.

Access restrictions.

Cost.

Eligibility barriers.

These are the conversations that dominate real user communities.

Not whether a CGM looks stylish.

That does not mean visibility is irrelevant.

But it does mean the “normalisation” narrative should be treated with some caution.

Who actually benefits?

This is where the conversation becomes more revealing.

When a CGM appears in celebrity fashion coverage, what changes for diabetes users?

Not much.

A fashion headline does not improve sensor accuracy.

It does not solve adhesion problems.

It does not widen NHS access.

It does not reduce cost.

It does not make hybrid-closed loop technology more accessible.

But it can create something commercially valuable.

Broader cultural desirability.

A glucose sensor framed as sleek wearable technology rather than diabetes-specific medtech becomes easier to market to wider audiences.

That expands opportunity.

From diabetes users.

To wellness consumers.

To athletes.

To biohackers.

To health optimisers.

From a business perspective, this is logical.

That does not mean it automatically benefits people who rely on CGMs for their intended purpose.

Why the original purpose still matters

CGMs were developed to help people manage a serious condition.

To improve glucose visibility.

To reduce dangerous highs and lows.

To support insulin decisions.

To reduce finger-prick burden.

To integrate with hybrid-closed loop systems.

That matters.

Because there is a meaningful difference between using a CGM to help avoid overnight hypoglycaemia and using one to analyse post-lunch glucose trends out of curiosity.

The hardware may look similar.

The stakes are entirely different.

That distinction can become blurred when glucose monitoring is reframed as mainstream wearable lifestyle technology.

Particularly while some diabetes users still face access or affordability barriers.

Personal expression is different from fashion trend

Rejecting the fashion narrative does not mean rejecting personalisation.

People have customised diabetes tech for years.

Decorative patches.

Protective covers.

Patterned accessories.

Practical solutions that also feel personal.

That is not trend chasing.

It is ownership.

If you wear a sensor day and night, wanting it to feel less clinical is understandable.

That is very different from treating essential medtech as a celebrity trend piece.

What meaningful progress actually looks like

For most CGM users, progress looks like something much less glamorous.

Better accuracy.

Fewer failures.

Longer wear.

Better comfort.

Improved adhesion.

Less skin irritation.

Reduced alarm fatigue.

Broader access.

Lower cost.

Better hybrid-closed loop integration.

Those changes improve lives.

Fashion headlines do not.

Love My Libre’s view

A CGM is not a fashion accessory.

It is essential medtech.

If people choose to personalise it or wear it confidently, that is entirely understandable.

But celebrity visibility should not be confused with meaningful progress.

A CGM appearing in fashion headlines may help medtech brand awareness.

It may support the commercial expansion of glucose monitoring into wellness.

It may create larger markets for companies.

That does not automatically benefit people managing diabetes.

For most users, the priorities remain far simpler.

Accuracy.

Reliability.

Comfort.

Access.

Affordability.

And keeping the sensor exactly where it belongs.

FAQ

Why are CGMs being worn by people without diabetes?

Some CGM products are now marketed to wellness consumers interested in nutrition, fitness or metabolic tracking rather than diabetes management.

Are CGMs becoming fashion accessories?

No. CGMs remain essential diabetes medtech, although growing consumer wellness adoption has changed public perception.

What is a CGM used for?

A CGM helps track glucose levels in real time and is widely used by people managing diabetes.

Why do some people personalise glucose sensors?

Some users personalise sensors for practical protection, comfort or to make wearable medtech feel less clinical.

---